Cite
HARVARD Citation
Jensen, K. et al. (n.d.). MO-0390 CCI and TNM stage do not influence early mortality risk after definitive radiotherapy in NSCLC. Radiotherapy and oncology. pp. S326-S327. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jensen, K. et al. (n.d.). MO-0390 CCI and TNM stage do not influence early mortality risk after definitive radiotherapy in NSCLC. Radiotherapy and oncology. pp. S326-S327. [Online].